Acer Therapeutics is a pharmaceutical company focused on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases with unmet medical need. The company's pipeline includes three clinical-stage candidates: EDSIVO? (celiprolol) for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001 (a fully taste-masked, immediate release formulation of sodium phenylbutyrate) for the treatment of various inborn errors of metabolism, including urea cycle disorders and Maple Syrup Urine Disease; and osanetant for the treatment of various neuroendocrine disorders.

Atlanticus Holdings is a holding company. Through its subsidiaries, the company provides various credit and related financial services and products. The company has two segments: Credit and Other Investments, whereby the company supports lenders who originate consumer loan products that include retail credit and credit cards marketed through various channels, including retail point-of-sale, direct mail solicitation, and partnerships with third parties; and Auto Finance, which purchases and/or services loans secured by automobiles from or for, and also provides floor plan financing for, a pre-qualified network of automotive dealers and automotive finance companies in the buy-here, pay-here, used car business.

Bassett Furniture Industries is a retailer, manufacturer and marketer of branded home furnishings. The company's products are sold primarily through a network of the company-owned and licensee-owned branded stores under the Bassett Home Furnishings (BHF) name. The company's wholesale home furnishings segment is involved principally in the design, manufacture, sourcing, sale and distribution of furniture products to a network of BHF stores and independent furniture retailers. The company's Retail segment includes its store network of the company-owned stores and licensee-owned stores. The company's Logistical Services segment provides network line haul freight (middle mile) and warehousing, distribution and inventory management.

Cadence is a bank holding company. The company is engaged in commercial lending to middle-market customers and provide a range of commercial loans to middle-market commercial businesses, individuals and business owners. The company's loan portfolio includes commercial and industrial loans, residential real estate loans, commercial real estate loans and other consumer loans. The company also provides its customers a variety of deposit products, including checking accounts, savings accounts, money market accounts and other deposit accounts, through multiple channels, including its network of full-service branches, drive-thru branches, ATMs, ITMs, and its online, mobile and telephone banking platforms.

Genocea Biosciences is a biopharmaceutical company that discovers and develops cancer vaccines. The company uses its platform, AnTigen Lead Acquisition System (ATLAS?), to recall a patient's pre-existing CD4+ and CD8+ T cell immune responses to their tumor to identify antigens for inclusion in vaccines that are designed to act through T cell (or cellular) immune responses. The company's product candidate, GEN-003, an immunotherapy for the treatment of genital herpes. The company's preclinical immuno-oncology program, GEN-009, a neoantigen cancer vaccine. The GEN-009 program uses ATLAS to identify patient neoantigens, or newly formed antigens unique to each patient, that are associated with that individual's tumor.

NGM Biopharmaceuticals is a biopharmaceutical company. The company is focused on the following programs: Aldafermin, which is for the treatment of non-alcoholic steatohepatitis (NASH); NGM313 (MK-3655), which is for the treatment of NASH and type 2 diabetes; NGM120, which is designed to block the effects of elevated growth differentiation factor 15 levels on cancer anorexia/cachexia syndrome, and, possibly, tumors; NGM217, which is designed to restore pancreatic islet function and increase insulin production in patients with diabetes; NGM621, which is designed to decrease levels of this protein implicated in the dry form of AMD; and NGM395, which is for the treatment of metabolic syndrome.

Pluristem Therapeutics is a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The company's product candidates include: PLX-PAD, which is in a multinational clinical trial in critical limb ischemia, and in a multinational clinical trial in recovery following surgery for hip fracture; PLX-R18, which is under development in the United States for acute radiation syndrome, as well as in a trial in the United States and Israel for incomplete hematopoietic recovery following hematopoietic cell transplantation; and PLX-Immune, which is under pre-clinical development for treatment of certain types of human cancer.

ServiceSource International is engaged in outsourced customer success and revenue growth solutions. The company's solutions span the lifecycle of its clients' customers, from landing new customers (Co. provides lead generation, inside sales, and outsourced sales operations services), adoption (Co. provides customer onboarding and customer success management services), expansion (Co. provides cross-sell and upsell, warranty conversion, account-based marketing and channel recruitment and enablement) and renewals (Co. provides renewals management services, including the sale of maintenance and support service contracts for the products used by its clients' end-users).

United Airlines Holdings is a holding company and its principal, wholly-owned subsidiary is United Airlines, Inc. (United). The company is engaged in the transportation of people and cargo throughout North America and to destinations in Asia, Europe, Africa, the Pacific, the Middle East and Latin America. The company, through United and its regional carriers, operates flights to airports, with its hubs at Newark Liberty International Airport, Chicago O'Hare International Airport, Denver International Airport, George Bush Intercontinental Airport, Los Angeles International Airport, A.B. Won Pat International Airport, San Francisco International Airport and Washington Dulles International Airport.